CDER Launches the ARC Program to Expedite Treatment Options for Rare Diseases

Retrieved on: 2022-05-20 18:47:51

Tags for this article:

Health sciences

Life Sciences

Food and Drug Administration

Health

Drug discovery

Pharmaceutical industry

Pharmaceuticals policy

Orphan drug

Critical Path Institute

Rare disease

Clinical trial

Food and Drug Administration Amendments Act

Click the tags to see associated articles and topics

CDER Launches the ARC Program to Expedite Treatment Options for Rare Diseases. View article details on HISWAI: https://www.wsgr.com/en/insights/cder-launches-the-arc-program-to-expedite-treatment-options-for-rare-diseases.html

Excerpt

As part of the Rare Disease Cures Accelerator, in 2019, the FDA launched a data analytics platform, called the Rare Disease Cures Accelerator–Data ...

Article found on: www.wsgr.com

View Original Article